The endocrine system is a group of glands that create and release hormones to control important bodily functions, such as metabolism, growth, reproduction etc. The endocrine system plays a vital role in prevention of several chronic and metabolic diseases. Generally, endocrine disorders are divided into two categories: diseases resulting when the glands over-produce or under-produce (hormone imbalance) and diseases sue to development of lesions in the endocrine system.
The purpose of this research study titled ‘Endocrine Testing Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global endocrine testing market. This report presents and analyzes the major trends prevalent in the global endocrine testing market and the market size and forecast.
This report categorizes the global endocrine testing market in terms of test type, endocrine disorder, testing technology, end-users and geographical distribution. For the purpose of this study, the test types considered include estradiol (E2) testing, follicle stimulating hormone (FSH) testing, human chorionic gonadotropin (hCG) hormone testing, luteinizing hormone (LH) testing, dehydroepiandrosterone sulfate (DHEAS) testing, progesterone testing, testosterone testing, thyroid stimulating hormone (TSH) testing, prolactin testing, cortisol testing, insulin testing and others. The endocrine disorders studied in this report are categorized as adrenal disorders, calcium problems, glucose (islet cells) disorders, male and female gonadal problems, hypertensive and heart disorders, thyroid disorders and pituitary disorders.
Based on testing technologies, the global endocrine testing market is studied for immunoassay technology, tandem mass spectrometry, sensors technology, monoclonal and polyclonal antibody technology, clinical chemistry technology and others. This report also categorizes the global endocrine testing market by end-users such as hospitals, clinical laboratories, research and academia, and others. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.
Geographically, the global endocrine testing market is best understood by segmenting the market into five major regions and chief region level markets as follows:
The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional analysis is presented in terms of test type, endocrine disorder, testing technology, end-users and constituent region/country level markets.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global endocrine testing market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the endocrine testing market. The key players profiled in this report are Abbott Laboratories, AB Sciex Pte Ltd., Agilent Technologies, Inc., Biomedical Technologies (Alfa Aesar), bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Ortho-clinical Diagnostics, Quest Technology Pte Ltd., Sysmex Corporation and Teleflex Incorporated.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Endocrine Testing Market Portraiture
2.2 Global Endocrine Testing Market, by Test Type, 2016 (US$ Mn)
2.3 Global Endocrine Testing Market, by Disorder, 2016 (US$ Mn)
2.4 Global Endocrine Testing Market, by Testing Technology, 2016 (US$ Mn)
2.5 Global Endocrine Testing Market, by End-user, 2016 (US$ Mn)
2.6 Global Endocrine Testing Market Share, by Geography, 2016 Vs 2025 (Value %)
Chapter 3 Global Endocrine Testing Market Analysis
3.1 Market Overview
3.2 Market Drivers
3.2.1.1 Growing Incidence of Hormonal Disorders
3.2.1.2 Advancement in Diagnostic Methods and Assays
3.2.2 Challenges
3.2.2.1 Challenged Adoption in Resource-poor Settings
3.2.3 Opportunities
3.2.3.1 Growing Initiatives towards Facilitating Early Diagnosis
3.3 Attractive Investment Proposition
3.4 Competitive Landscape: Endocrine Testing Market, by Key Players
Chapter 4 Global Endocrine Testing Market, by Test Type
4.1 Overview
4.2 Estradiol (E2) Testing
4.3 Follicle Stimulating Hormone (FSH) Testing
4.4 Human Chorionic Gonadotropin (hCG) Hormone Testing
4.5 Luteinizing Hormone (LH) Testing
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Testing
4.7 Progesterone Testing
4.8 Testosterone Testing
4.9 Thyroid Stimulating Hormone (TSH) Testing
4.10 Prolactin Testing
4.11 Cortisol Testing
4.12 Insulin Testing
4.13 Others
Chapter 5 Global Endocrine Testing Market, by Disorder
5.1 Overview
5.2 Adrenal Disorders
5.3 Calcium-Related Disorders
5.4 Glucose (Islet Cells) Disorders
5.5 Male and Female Gonadal Problems
5.6 Hypertensive & Heart Disorders
5.7 Thyroid Disorders
5.8 Pituitary Disorders
Chapter 6 Global Endocrine Testing Market, by Testing Technology
6.1 Overview
6.2 Immunoassay Technology
6.3 Tandem Mass Spectrometry
6.4 Sensors Technology
6.5 Monoclonal and Polyclonal Antibody Technology
6.6 Clinical Chemistry Technology
6.7 Other Technologies
Chapter 7 Endocrine Testing Market, by End-user
7.1 Introduction
7.2 Hospitals
7.3 Clinical Laboratories
7.4 Research and Academia
Chapter 8 Global Endocrine Testing Market, by Geography, 2015-2025 (US$ Mn)
8.1 Preface
8.2 North America (U.S. and Canada)
8.2.1 North America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.2.2 North America Endocrine Testing Market, by Disorders, 2015 – 2025 (US$ Mn)
8.2.3 North America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.2.4 North America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.2.5 North America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.3 Europe (U.K., Germany, France, Italy, Spain and Rest of Europe)
8.3.1 Europe Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.3.2 Europe Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.3.3 Europe Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.3.4 Europe Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.3.5 Europe Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.4 Asia Pacific (China, Japan, and Rest of APAC)
8.4.1 Asia Pacific Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.4.2 Asia Pacific Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.4.3 Asia Pacific Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.4.4 Asia Pacific Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.4.5 Asia Pacific Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.5 Latin America (Mexico, Brazil and Rest of LATAM)
8.5.1 Latin America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.5.2 Latin America Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.5.3 Latin America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.5.4 Latin America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.5.5 Latin America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.6 Middle East and Africa (GCC & Rest of Middle East and Africa)
8.6.1 Middle East and Africa Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.6.2 Middle East and Africa Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.6.3 Middle East and Africa Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.6.4 Middle East and Africa Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.6.5 Middle East and Africa Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
Chapter 9 Company Profiles
9.1 Abbott Laboratories, Inc.
9.2 Agilent Technologies
9.3 bioMerieux S.A.
9.4 Bio-Rad Laboratories, Inc.
9.5 DiaSorin S.p.A.
9.6 F. Hoffmann-La Roche AG
9.7 Ortho Clinical Diagnostics
9.8 SCIEX (Danaher Corporation)
9.9 Siemens AG
9.10 Thermo Fisher Scientific, Inc.
List of Tables
TABLE 1 Global Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 3 Global Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 4 Global Endocrine Testing Market, by End-user, 2015-2025 (US$ Mn)
TABLE 5 Global Endocrine Testing Market, by Geography, 2015 –2025 (US$ Mn)
TABLE 6 North America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 8 North America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 9 North America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 10 North America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 15 Europe Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Endocrine Testing Market, By Disorder, 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 19 Asia Pacific Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 20 Asia Pacific Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 24 Latin America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 25 Latin America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 27 Middle East and Africa Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 28 Middle East and Africa Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 29 Middle East and Africa Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 30 Middle East and Africa Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 31 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 32 Agilent Technologies: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 33 bioMerieux S.A.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 34 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 35 DiaSorin S.p.A.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 36 F. Hoffmann-La Roche AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 37 Ortho Clinical Diagnostics: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 38 SCIEX (Danaher Corporation): Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 39 Siemens AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 40 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
List of Figures
FIG. 1 Endocrine Testing Market: Research Methodology
FIG. 2 Global Endocrine Testing Market, by Test Type, 2016 (US$ Mn)
FIG. 3 Global Endocrine Testing Market, by Disorder, 2016 (US$ Mn)
FIG. 4 Global Endocrine Testing Market, by Testing Technology, 2016 (US$ Mn)
FIG. 5 Global Endocrine Testing Market, by End-user, 2016 (US$ Mn)
FIG. 6 Global Endocrine Testing Market Share, by Geography, 2016 Vs 2025 (Value %)
FIG. 7 Attractive Investment Proposition: Global Endocrine Testing Market, by Geography, 2016
FIG. 8 Competitive Landscape: Endocrine Testing Market, by Key Players, 2016
FIG. 9 Estradiol (E2) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 10 Follicle Stimulating Hormone (FSH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 11 Human Chorionic Gonadotropin (hCG) Hormone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 12 Luteinizing Hormone (LH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 13 Dehydroepiandrosterone Sulfate (DHEAS) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 14 Progesterone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 15 Testosterone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 16 Thyroid Stimulating Hormone (TSH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 17 Prolactin Testing Market, 2015 – 2025 (US$ Mn)
FIG. 18 Cortisol Testing Market, 2015 – 2025 (US$ Mn)
FIG. 19 Insulin Testing Market, 2015 – 2025 (US$ Mn)
FIG. 20 Others Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Endocrine Testing Market for Adrenal Disorders, 2015 – 2025 (US$ Mn)
FIG. 22 Global Endocrine Testing Market for Calcium Related Disorders, 2015 – 2025 (US$ Mn)
FIG. 23 Global Endocrine Testing Market for Glucose (Islet Cells) Disorders, 2015 – 2025 (US$ Mn)
FIG. 24 Global Endocrine Testing Market for Male and Female Gonadal Problems, 2015 – 2025 (US$ Mn)
FIG. 25 Global Endocrine Testing Market for Hypertensive & Heart Disorders, 2015 – 2025 (US$ Mn)
FIG. 26 Global Endocrine Testing Market for Thyroid Disorders, 2015 – 2025 (US$ Mn)
FIG. 27 Global Endocrine Testing Market for Pituitary Disorders, 2015 – 2025 (US$ Mn)
FIG. 28 Global Endocrine Testing Market for Adrenal Disorders, 2015 – 2025 (US$ Mn)
FIG. 29 Global Endocrine Testing Market for Tandem Mass Spectrometry, 2015 – 2025 (US$ Mn)
FIG. 30 Global Endocrine Testing Market for Sensors Technology, 2015 – 2025 (US$ Mn)
FIG. 31 Global Endocrine Testing Market for Monoclonal and Polyclonal Antibody Technology, 2015 – 2025 (US$ Mn)
FIG. 32 Global Endocrine Testing Market for Clinical Chemistry Technology, 2015 – 2025 (US$ Mn)
FIG. 33 Global Endocrine Testing Market for Other Technologies, 2015 – 2025 (US$ Mn)
FIG. 34 Hospitals Market for Endocrine Testing, 2015 – 2025 (US$ Mn)
FIG. 35 Clinical Laboratories Market for Endocrine Testing, 2015 – 2025 (US$ Mn)
FIG. 36 Research and Academia Market for Endocrine Testing, 2015 – 2025 (US$ Mn)
Based on the type of disorders, the global endocrine testing market is segmented as follows:
Diabetes is among the most prominent areas where endocrine testing is widely used. As the global prevalence of diabetes is on perpetual rise, it is also opined that there is still a huge population of undiagnosed patients. People can have prediabetes or type 2 diabetes for several years without exhibiting distinguishable symptoms. As a matter of fact, type 2 diabetes often goes undiagnosed until the related complications appear. Such complications include renal disease, vision impairment and even nerve damage. If not diagnosed in time, and left untreated, diabetes can result in several complications and eventual mortality. Efficient and accurate diagnosis of diabetes is very critical to make the needed lifestyle changes or take medications for disease management. It is often recommended to perform diabetes screening in people with high risk of developing diabetes.
For the purpose of this study, global endocrine testing market is studied for the following test types:
Among the considered test types, thyroid stimulating hormone testing and insulin testing together will capture the largest market share throughout the forecast period 2017-2025. Thyroid function disorders are common worldwide and screening and diagnosis forms a critical part of disease management. Symptoms of thyroid disorders are extremely prevalent in general population and are non-specific. Increasing information available too general public has let to voluntary testing by patients worldwide. TSH, T4 and anti-TPO antibodies are the three most important biochemical tests for assessing thyroid function. Of these, the TSH testing assay is the most reliable test for diagnosis of primary hypo- and hyperthyroidism, where the first generation TSH testing can only diagnose hypothyroidism.
For the purpose of this study, the global endocrine testing market is segmented as per the following technologies:
Growing prevalence of metabolic disorders, sexual dysfunction, diabetes, renal diseases and obesity has led to emergence of heightened demand for endocrine testing methods. Regular monitoring of endocrine hormones play a critical role in the management of diabetes and related complications across all demographics. There is also an increasing significance of obesity as co-morbidity in the growing prevalence of disorders of the reproductive system, strokes, cardiovascular diseases and cancer. This increase in the patient pool is expected to favor the growth of endocrine testing market. However, high costs of novel testing technologies may restrain widespread acceptance of novel tests, especially in developing countries. Among the currently available testing technologies, immunoassay technology is the largest revenue generating segment and it is anticipated that the trend shall continue during the forecast period. Technologies such as tandem mass spectrometry will witness significant traction through the forecast period as a result of their proven precision and accuracy in result delivery.
Geographically, the global endocrine testing market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
North America (U.S. and Canada) is the clear leader in the global endocrine testing market, followed by Europe. Significant prevalence of obesity, chronic endocrine disorders such as diabetes and thyroid diseases, and reproductive health disorders are the key factors contributing to the dominance of North America market. Furthermore, supportive government regulations facilitating swift adoption of novel testing technologies and evolved reimbursement scenario additionally drive the North America endocrine testing market. On the other hand, huge population base and rising incidence of lifestyle-related diseases has led to the emergence of Asia Pacific as the fastest progressing regional market for endocrine testing.
The detailed regional classification of the global endocrine testing market is as follows:
